top of page

Meet Doctor
Ardalan Minokadeh

2174d68eacebdfdb74ee0433982a5e4f.jpg

Dr. Ardalan is a board-certified cosmetic dermatologist at Skin Care and Laser Physicians of Beverly Hills, specializing in advanced cosmetic dermatology procedures, including neuromodulators, fillers, lasers, and skin rejuvenation treatments. With a distinguished academic and training background, Dr. Ardalan combines innovative techniques with a patient-centered approach, ensuring natural and transformative results tailored to each individual's needs.

Dr. Ardalan completed his Cosmetic Dermatologic Surgery Fellowship at Skin Care and Laser Physicians of Beverly Hills, where he focused on toxins, fillers, lasers, and peer-reviewed dermatologic research under the mentorship of Dr. Derek Jones and Dr. Naissan Wesley. He completed his Dermatology Residency at Tulane University Health Sciences Center, where he served as Chief Resident of Medical Education, and his Internal Medicine Internship at the same institution. Dr. Minokadeh earned his M.D. and Ph.D. through Tulane University’s prestigious, tuition-free Physician/Scientist Program, conducting advanced neuroscience research on neurotransmitter biosynthesis mechanisms. Additionally, he holds a Bachelor of Science in Neuroscience, graduating cum laude from Tulane University.

Dr. Ardalan's expertise is complemented by his involvement in numerous FDA clinical trials, advancing treatments in Botox, fillers, and other innovative cosmetic dermatology procedures. His extensive education, hands-on training, and commitment to research position him as a leader in the field, dedicated to providing exceptional care and transformative results to his patients.

Clinical Trials

  • 2024-Present: Investigator, BOTOX® (onabotulinumtoxinA) for the reduction of masseter muscle prominence (Phase 3).

  • 2022-Present: Sub-Investigator, SMA-001 for correction of moderate to severe nasolabial folds.

  • 2022-Present: Sub-Investigator, Precise Sculpt Dermal Filler for midface age-related volume deficits.

  • 2022-Present: Sub-Investigator, Restylane Contour for temple hollowing.

  • 2021-Present: Sub-Investigator, GP0112 for cheek augmentation and midface volumization.

  • 2021-2023: Sub-Investigator, BOTOX® (Botulinum Toxin Type A) for platysma prominence (Phase 3).

  • 2021-2023: Sub-Investigator, AGN-151586 for glabellar lines (Phase 3).

  • 2020-2022: Sub-Investigator, QM1114-DP for lateral canthal and glabellar lines (Phase 3).

  • 2020-2021: Sub-Investigator, Restylane-L for correction of infraorbital hollows (Phase 3).

  • 2019-2023: Sub-Investigator, JUVÉDERM VOLUMA® XC for temple hollowing.

  • 2017-2018: Sub-Investigator, asymmetrical facial volume loss from disproportionate light exposure study.

  • 2017-2018: Sub-Investigator, Daxxify (DaxibotulinumtoxinA) for moderate to severe glabellar lines.

  • 2017-2018: Sub-Investigator, JUVÉDERM Voluma-XC for cheek augmentation using cannula.

bottom of page